|
English
|
正體中文
|
简体中文
|
2828323
|
|
???header.visitor??? :
32249997
???header.onlineuser??? :
754
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"heo ds"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
中國醫藥大學 |
2005 |
Intrapatient dose escalation to 800 mg/m(2) pemetrexed is safe and feasible in patients with advanced non-small cell lung cancer (NSCLC) who have had prior chemotherapy.
|
Lee, JS; Hsia, TC; Yang, CH; Heo, DS; Chang, GC; Park, K; Kim, SW; Yildirim, H; Reece, WHH; Lehnert, M |
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
|